Table 1
Baseline lung functions
| FVC | FEV1 | FEV1/FVC | FEF25–75 | PEF |
---|
EVH placebo | 5.0 (0.81) | 4.1 (0.76) | 81.3 (8.58) | 3.9 (1.29) | 8.8 (1.33) |
| 106 (14.9) | 102 (14.5) | | 84.2 (27.6) | 100 (16.4) |
EVH montelukast | 4.8 (0.76) | 3.8 (0.67) | 79.4 (7.46) | 3.4 (1.08) | 8.5 (1.30) |
| 103 (15.8) | 95.5 (15.6) | | 72.9 (24.7) | 96.4 (15.1) |
EX placebo | 4.9 (0.84) | 4.0 (0.83) | 80.4 (6.42) | 3.7 (1.45) | 8.8 (1.17) |
| 105 (16.0) | 99.4 (15.4) | | 78.8 (26.8) | 99.2 (9.4) |
EX montelukast | 4.8 (0.84)* | 3.9 (0.69) | 80.9 (6.48) | 3.5 (0.99) | 8.7 (1.03) |
| 103 (14.4) | 97.3 (13.6) | | 76.0 (20.6) | 98.7 (11.7) |
Grand mean | | | | | |
Placebo | 5.0 (0.81) | 4.0 (0.78) | 80.9 (7.41) | 3.8 (1.34) | 8.8 (1.22) |
| 106 (15.0) | 101 (14.6) | | 81.5 (26.7) | 99.6 (13.1) |
Montelukast | 4.8 (0.78)* | 3.8 (0.67)* | 80.1 (6.86) | 3.4 (1.02) | 8.6 (1.15) |
| 103 (14.8) | 96.4 (14.3) | | 74.5 (22.3) | 97.6 (13.3) |